Start/ELV

Public research page

Market data comes from the live feed. The company research below uses verified public sources, but it is not a real-time personalized AI conclusion.

Analyze ELV in workspace
ELVNYSE/health care

Elevance Health, Inc.

$425.17Up+8,94 (+2,15%)
Research reviewed: 12. Juli 2026, 00:00 UTC
Research overview3-month price contextInvestment thesisKey catalystsLatest earnings researchRecent newsData and research sources

Research overview

Elevance Health, Inc. operates in Managed Health Care within the health care sector. This profile tracks its company-specific earnings drivers, valuation conditions, and primary-source risks.

Eröffnung
422,46
Hoch
426,46
Tief
419,62
Marktkapitalisierung
92,33 Mrd.
KGV
18.02
52-Wochen-Hoch
--
Dividende
1.650%
Quartalsdividende
--

3-month price context

Das Chart zeigt den jüngsten 3-Monats-Trend, damit Nutzer die kurzfristige Struktur verstehen können, bevor sie den vollen Workspace öffnen.

Investment thesis

Base case
Pharmacy, behavioral-health and care-delivery services can grow within Elevance plans and with external clients. The base case remains conditional on medicaid rate adequacy staying manageable.
Bull case
Pharmacy, behavioral-health and care-delivery services can grow within Elevance plans and with external clients. Disciplined pricing and product design can preserve margins as utilization changes. Scale in Medicaid and Medicare can support membership relationships when rates reflect care costs.
Bear case
State rates may lag acuity changes after eligibility redeterminations, compressing margins. Higher outpatient, pharmacy or specialty-care use can exceed premium assumptions. Payment rules, risk adjustment and benefit mandates can alter product economics.

Key catalysts

  • Carelon expansion

    Pharmacy, behavioral-health and care-delivery services can grow within Elevance plans and with external clients.

  • Commercial pricing

    Disciplined pricing and product design can preserve margins as utilization changes.

  • Government programs

    Scale in Medicaid and Medicare can support membership relationships when rates reflect care costs.

Principal risks

  • Medicaid rate adequacy

    State rates may lag acuity changes after eligibility redeterminations, compressing margins.

  • Medical utilization

    Higher outpatient, pharmacy or specialty-care use can exceed premium assumptions.

  • Regulatory exposure

    Payment rules, risk adjustment and benefit mandates can alter product economics.

Latest earnings research

Q1 2026

Elevance Health's first-quarter 2026 update reflected commercial and government health-benefit execution, expanding Carelon services and continued attention to Medicaid rates and medical-cost trends.

Valuation interpretation

  • A managed-care quality premium requires rate adequacy and underwriting discipline across both commercial and government books.
  • Carelon diversification is more valuable when external growth is visible and not solely dependent on affiliated plan volume.

Peer research

UNHCIABBV

Recent news

Zacks · vor 8 Stunden

Will Health Benefits Weakness Drag Elevance's Q2 Earnings?

Trefis · vor 8 Stunden

The Premium On CVS Stock Vs What Its Peers Deliver

Barrons.com · vor 19 Stunden

Elevance and UnitedHealth Earnings Are Next Test for Hot Health Insurer Stocks

Simply Wall St. · vor 3 Tagen

Elevance Health (ELV) Could Be Fully Valued After Lower Earnings And Revenue Forecasts

Simply Wall St. · vor 3 Tagen

Should Elevance Health’s (ELV) Index Shift and Softer Outlook Require Action From Investors?

Continue in the research workspace

Keep ELV in context, run a multi-agent analysis, and monitor thesis changes.

Analyze ELV free

Das gesamte Research-System erkunden

Jede Phase erfüllt eine klare Aufgabe und hinterlässt ein prüfbares Ergebnis.

AnalysemethodikMarktberichte lesen
Thesis invalidation
Reassess the thesis if state rates may lag acuity changes after eligibility redeterminations, compressing margins.

Zacks · vor 3 Tagen

Is ELV's Capital Allocation Strategy Creating Long-Term Value?

Data and research sources

Research updated: 12. Juli 2026, 00:00 UTC
3 verified sources
Elevance Health Reports First Quarter 2026 ResultsElevance Health, Inc. · earningsVerified

Fetched: 12.7.2026, 0:00:00 UTC

Published: 22.4.2026, 00:00:00

Open original source
Elevance Health, Inc. Investor RelationsElevance Health, Inc. · companyVerified

Fetched: 12.7.2026, 0:00:00 UTC

Open original source
Elevance Health SEC filings and company factsU.S. Securities and Exchange Commission · filingVerified

Fetched: 12.7.2026, 0:00:00 UTC

Published: 22.4.2026, 00:00:00

Open original source
Aktien erkunden

Continue researching this stock

Marktanalyst

Marktanalyst fokussiert sich innerhalb von Kernresearch auf die Phase Beobachten und bereitet den Kontext für nachgelagerte Rollen vor.

Fundamentalanalyst

Fundamentalanalyst fokussiert sich innerhalb von Kernresearch auf die Phase Beobachten und bereitet den Kontext für nachgelagerte Rollen vor.

Nachrichtenanalyst

Nachrichtenanalyst fokussiert sich innerhalb von Kernresearch auf die Phase Beobachten und bereitet den Kontext für nachgelagerte Rollen vor.

Risikomanager

Risikomanager fokussiert sich innerhalb von Risiko und Monitoring auf die Phase Überwachen und bereitet den Kontext für nachgelagerte Rollen vor.